$19.83
0.291.48%
最終更新: Oct 29, 4:00 PM
Benzinga
Benzinga
Benzinga
木曜日, 10 29
Benzinga
© 2026 Benzinga | All Rights Reserved
Odyssey Therapeutics (ODTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $-1.74 | $-0.85 | -104.7 % |
| Q1 | Jun 17, 2026 | $-6.77 | $-1.29 | -424.8 % |
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Estimate | $-0.85 | $-1.29 |
| Actual | $-1.74 | $-6.77 |
| Surprise | -104.7% | -424.8% |
| Revenue | ||
| Estimate | — | — |
| Actual | $0 | $0 |
| Surprise | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.97 | $-1.03 | $-1.25 | $-1.32 |
| Revenue | ||||
| Consensus | — | — | — | — |